Related Experiment Video
Updated: Jul 9, 2026

High Throughput Characterization of Adult Stem Cells Engineered for Delivery of Therapeutic Factors for Neuroprotective Strategies
Published on: January 4, 2015
Delivering growth factors for therapeutics
Eduardo Anitua1, Mikel Sánchez, Gorka Orive
1Biotechnology Institute I MAS D, c/ San Antonio 15, 01005 Vitoria, Spain.
Controlled drug delivery systems, including biomaterials and nanoparticles, enhance therapeutic efficacy by precisely releasing growth factors at injury sites. This review explores innovative technologies and their applications, focusing on Platelet-Rich Growth Factor (PRGF) technology.
Area of Science:
- Biomaterials Science
- Regenerative Medicine
- Drug Delivery Systems
Background:
- Therapeutic efficacy is significantly influenced by drug release kinetics.
- Controlled release of growth factors is critical for successful tissue repair and regeneration.
- Local and spatiotemporal delivery ensures optimal therapeutic outcomes at the site of injury.
Purpose of the Study:
- To review advanced drug delivery technologies for controlled spatiotemporal release of growth factors.
- To highlight therapeutic applications, with a focus on Platelet-Rich Growth Factor (PRGF) technology.
- To discuss current limitations and future challenges in the field of growth factor delivery.
Main Methods:
- Exploration of biomaterial-based delivery systems.
- Review of 3D micro- and nanoparticles for controlled release.
- Analysis of microspheres, gene therapy, and PRGF technology.
- Examination of therapeutic applications and case studies.
Main Results:
- Biomaterials, nanoparticles, microspheres, gene therapy, and PRGF technology offer promising avenues for controlled growth factor delivery.
- These technologies enable precise spatiotemporal release, enhancing therapeutic outcomes in regenerative medicine.
- PRGF technology shows significant potential in various therapeutic applications.
Conclusions:
- Advanced drug delivery systems are essential for optimizing growth factor-based therapies.
- Controlled local delivery enhances regenerative potential and therapeutic efficacy.
- Further research into PRGF technology and delivery systems is warranted to overcome existing challenges and advance clinical applications.
More Related Videos
09:34Visualizing Angiogenesis by Multiphoton Microscopy In Vivo in Genetically Modified 3D-PLGA/nHAp Scaffold for Calvarial Critical Bone Defect Repair
Published on: September 7, 2017
12:27Polyelectrolyte Complex for Heparin Binding Domain Osteogenic Growth Factor Delivery
Published on: August 22, 2016
Related Concept Videos
Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...
Mitogens and the Cell Cycle
TGF - β Signaling Pathway
Microorganisms in Medicine and Therapeutics
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Designing Growth Media for Bioreactors